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The RNase H cleavages that generate and remove the polypurine tract (PPT) primer during retroviral reverse transcription must be specific to
generate linear viral DNAs that are suitable substrates for the viral integrase. To determine if specific contacts between reverse transcriptase (RT)
and the PPT are a critical factor in determining the cleavage specificity of RNase H, we made HIV-1 viruses containing mutations in RT and the
PPT at the locations of critical contacts between the protein and the nucleic acid. The effects on titer and RNase H cleavage suggest that combining
mutations in RTwith mutations in the PPT affect the structure of the protein of the RT/nucleic acid complex in ways that affect the specificity and
the rate of PPT cleavage. In contrast, the mutations in the PPT (alone) and RT (alone) affect the specificity of PPT cleavage but have much less
effect on the overall rate of cleavage.
Published by Elsevier Inc.Keywords: HIV-1 reverse transcriptase; Polypurine tract; RNase H cleavage specificityIntroduction
Reverse transcription and integration, the copying of the
single-stranded RNA genome found in virions into double-
stranded linear DNA and the subsequent insertion of this
DNA into the host genome, are the hallmarks of retroviral
replication (Coffin et al., 1997; Whitcomb and Hughes,
1992). The conversion of the retroviral RNA genome into
DNA is performed by the viral enzyme reverse transcriptase
(RT). RT has two enzymatic activities that are essential for
retroviral replication: a DNA polymerase that can copy either
an RNA or a DNA template and an RNase H that cleaves
RNA if, and only if, the RNA is part of an RNA–DNA
duplex (Repaske et al., 1989; Schatz et al., 1990; Tisdale et
al., 1991). In retroviral replication, the primer used to initiate⁎ Corresponding author. Fax: +1 301 846 6966.
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doi:10.1016/j.virol.2005.12.042the first, or minus, strand DNA is a host tRNA that is base-
paired near the 5′ end of the RNA genome (Coffin et al.,
1997; Whitcomb and Hughes, 1992). Synthesis of the second
(plus) strand of viral DNA is initiated from a primer derived
from the RNA genome by RNase H cleavage (Coffin et al.,
1997; Pullen and Champoux, 1990; Rattray and Champoux,
1989). The plus-strand segment of the viral genome used as
the second-strand primer is purine-rich and is called the
polypurine tract (PPT). The PPT is relatively resistant to
RNase H cleavage, which allows it to be used as the primer
for second-strand DNA synthesis. The removal of the RNA
primers used to initiate the minus and plus DNA strands
defines the ends of the linear viral DNA. Most cleavages by
RNase H do not need to be specific; however, the cleavages
that generate the PPT and remove the PPT and tRNA primers
must be specific in order to generate linear DNAs that are
appropriate substrates for integrase. The PPT primer is
removed at the RNA/DNA junction (Kulkosky et al., 1990;
379M.J. McWilliams et al. / Virology 348 (2006) 378–388Pullen and Champoux, 1990; Pullen et al., 1993; Whitcomb
et al., 1990); the tRNA primer is cleaved one nucleotide into
the tRNA for HIV-1. Consequently, the 5′ most nucleotide on
the minus-strand of the completed linear viral DNA is ribo-A
derived from the 3′ most nucleotide of the tRNA primer
(Furfine and Reardon, 1991; Pullen et al., 1992; Smith and
Roth, 1992; Whitcomb et al., 1990). The ability of RNase H
to make these specific cleavages in the absence of any
specific sequence motifs has been explored at both the
biochemical and structural level with a particular emphasis on
the cleavages that generate and remove the PPT of HIV-1
(Dash et al., 2004; Guaitiao et al., 2004; Kopka et al., 2003;
Kvaratskhelia et al., 2002; Powell and Levin, 1996; Pullen et
al., 1993; Rausch et al., 2002; Sarafianos et al., 2001; Smith
et al., 1999; Snyder and Roth, 2000). The available data
suggest that it is the structure of the nucleic acid when it is
bound to RT and the interactions between RT and the nucleic
acid substrate that determine the specificity of the PPT
cleavages.
The crystal structure of RT in a complex with the RNA–
DNA substrate, together with the structures of RT in complexes
with DNA–DNA substrates, provides useful information about
the contacts between RT and its nucleic acid substrates (Huang
et al., 1998; Jacobo-Molina et al., 1993; Sarafianos et al., 2001).
RT makes numerous contacts with its nucleic acid substrates
through both the polymerase domain and the RNase H domain.
The two domains cooperate in binding the nucleic acid, and
mutations in either the RNase H domain or the polymerase
domain can affect both enzymatic activities (Dudding and
Mizrahi, 1993; Dudding et al., 1991; Gao et al., 1998; Hughes et
al., 1998; Julias et al., 2002; Mizrahi et al., 1990, 1994).
However, there are elements near the polymerase active site that
have a particularly important role in positioning the nucleic acid
for polymerization (for example, the primer grip) and there are
elements near the RNase H active site (in particular the RNase H
primer grip) that are especially important in positioning theFig. 1. The sequence of the PPT, the numbering of the G-tract in the PPTand the conta
the PPT. (A) The sequence of the PPT and flanking sequences are shown. The PPT
subscript. The RNase H cleavage site defines the PPT/U3 junction and is designated b
The small green circles between the bases in the PPT (RNA) represent the ribose-pho
represent the deoxyribose-phosphate backbone. Solid black arrows represent contacts
when RT is bound for cleavage at the PPT/U3 junction. In this mode, the RNA strand
the RNase H domain (to the left in the drawing). These types of contacts exist for Q
(yellow) and the deoxyribose backbone of the minus-strand. The red arrow representnucleic acid for RNase H cleavage (Julias et al., 2002; Rausch et
al., 2002). Additionally, sequence-dependent properties of the
nucleic acid substrate such as the width of the minor groove and
the trajectory of the RNA/DNA hybrid are important for the
cleavage of substrates, or the resistance of substrates to
cleavage, by RNase H. For example, A-tracts have a narrow
minor groove width; the presence of the A-tracts in the 5′ end of
the PPT should (help) position the RNA strand away from the
RNase H active site and contribute to the PPT's resistance to
RNase H cleavage (Sarafianos et al., 2001).
We have identified elements in both the PPT and the RNase
H primer grip that are important for defining RNase H cleavage
specificity. Based on alanine scanning mutagenesis, we
identified Y501 and Q475 as two amino acids that are
particularly important for proper RNase H cleavages (Julias et
al., 2002; Rausch et al., 2002). When HIV-1 RT is modeled with
the RNase H active site at the PPT/U3 junction, the 6
nucleotides of the PPT that lie immediately upstream of the
cleavage site are all Gs (see Fig. 1A). This segment of the HIV-1
PPT is called the G-tract. If a model is generated in which an
RNA–DNA duplex containing the PPT is positioned with the
RNase H active site at the PPT/U3 junction, Y501 would
contact the phosphate backbone of the DNA strand between 5
and 6 nucleotides upstream (3′) of the cleavage site (see Fig.
1B). Q475 contacts the DNA strand 4 nucleotides upstream of
the cleavage site (through the deoxyribose ring) and, also
through the deoxyribose ring, 5 nucleotides upstream of the
cleavage site. Q475 contacts the RNA strand 1 nucleotide
upstream of the cleavage site (through the ribose ring) and also
contacts the RNA strand through a base-specific contact with
the exocyclic amine of G5. This is the only base-specific contact
that RT makes near the RNase H active site. We have mutated
each of the Gs in the G-tract of the PPT and assessed the effects
of the mutations on viral replication and on PPT cleavage (Julias
et al., 2004). Mutations in G2 and G5 (especially G to T
transversions, these mutants are called T-2 and T-5) had thects between Y501 and Q475 in HIV-1 RTand an RNA/DNA duplex that contains
is underlined, and the positions of the G-tract are numbered (1 through 6) in
y the arrow. (B) The sequences of the PPTand the minus-strand DNA are shown.
sphate backbone; the small blue circles between the bases in the (−) strand DNA
between the amino acids and the ribose-phosphate backbone in the PPT (RNA)
is the template strand and the polymerase domain contacts the RNA strand 5′ of
475 (pale bluish-green). Gray arrows represent contacts between Q475 or Y501
s the (major groove) contact between Q475 and the guanine base at position G5.
Fig. 2. Sequences and relative titers of RT and PPT mutants. The sequences of
the mutant PPTs are shown in the left column. Mutations in the PPT are in bold-
type face. The right column shows the relative titers of the mutants viruses. The
virus titers were determined by labeling virus-infected cells with antibody
directed against the cell-surface HSA followed by FACS. The relative virus titers
were calculated from the linear range of virus dilution (see Materials and
methods).
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mutant (T-2-5, in which both of the Gs were converted to Ts)
had a greater effect than either single G to T mutation. These in
vivo data are in reasonably good (but not perfect) agreement
with published data derived from in vitro RNase H cleavage
assays (Dash et al., 2004; Julias et al., 2002; Kvaratskhelia et al.,
2002; McWilliams et al., 2003; Pullen et al., 1993). The in vivo
data suggest that the contacts involving the G2 and G5
nucleotides and Y501 and Q475 might be particularly
important. Alternatively, Y501 and Q475, and G2 and G5,
might have particularly important roles in determining the
overall structure of the protein/nucleic acid complex that directs
the proper PPT cleavages.
To try to resolve these possibilities, we constructed complex
mutants that have the Y501A mutation combined with a G to T
mutation in G2 and G5 (T-2 and T-5) and also made the
equivalent mutants by combining a Q475A mutation and these
same G-to-T mutations. Because the effects of a mutant (T-2-5)
with two positions changed in the PPTwere stronger than either
of the single T substitutions, we also made mutants in which the
Y501A mutation and the Q475A mutation were each combined
separately with the T-2-5 mutation. If the critical issue is the
contacts between the individual amino acids and the respective
nucleotides, then mutating the nucleic acid and amino acid
involved in an important contact (for example, Y501A
combined with T-2) which would involve only a single contact
should not have as great an effect on viral replication as would
combining Y501A with T-5 because the latter combination
would disrupt two contacts. In contrast, if the mutations have
some important effect on the overall structure, combining the
PPTand RTmutations will have a profound effect whether or not
the mutations in the PPT and the RT are involved in a specific
contact. The data show that combining the RTmutations with the
PPT mutations has powerful effects on the titer of the virus and
on the specificity and the rate of PPT cleavage in all cases,
whether the combined RT and PPT mutations do or do not
involve a single contact. This suggests that the RT and/or the
PPT mutations affect the structure of protein and/or the PPT in
the RT/nucleic complex in ways that go beyond disrupting
individual contacts between RT and the PPT.
Results
The one-round HIV-1-based viral vector pNLNgoMIVR-E-.
HSA has been described [(Julias et al., 2001) see also Materials
and methods]. Basically, the vector expresses the murine heat-
stable antigen (HSA, CD24) from the nef open reading frame.
HSA is a surface protein that can easily be detected on the
surface of infected cells with a specific monoclonal antibody.
The mutations in RT (Y501A and Q475A) have been described,
as have the mutations in the G-tract region of the PPT: T-2, T-5
and T-2-5 (Julias et al., 2002, 2004). Mutants were constructed
in which each of the mutations in RT was paired with the
mutations in the PPT. Viral stocks were generated by
transfecting 293 cells (see Materials and methods); viruses
were harvested and used to infect HOS cells. The infected cells
were labeled with antibody directed against CD24, and the virustiters were measured by FACS. The titers of the combined
RT + PPT mutants were lower than the titer of the single
mutants from which they were constructed (Fig. 2). However, in
contrast to the data obtained with the PPT mutations alone,
when the PPT mutations were combined with either the Y501A
or the Q475A RT mutations, the effect of changing two of the
Gs in the G-tract (T-2-5) was not markedly worse than having
either of the single changes in the G-tract (T-2 or T-5). In fact,
the lowest titers were obtained with the Y501A + T-2 double
mutant (0.01 of wild-type); this is lower than either the titer of
Y501A + T-5 (0.14 of wild-type) or Y501A + T-2-5 (0.08 of
wild-type). The addition of the Y501A mutation did not
significantly affect the titer of the T-2-5 mutation (0.08 vs.
0.10). The titers of the Q475A + PPT mutants ranged from 0.05
of wild-type (for the Q475A + T-2 mutant) to 0.10 (for the
Q475A + T-5). A mutant that had the Q475A mutation
combined with the double G-tract mutation, T-2-5, had a titer
(0.07) which is slightly lower than the Q475Amutant (0.20) and
similar to the T-2-5 mutant (0.10).
The mutations in the RT and the PPT (either individually or
in combination) could affect either the specificity of PPT
cleavage, or the rate of PPT cleavage, or both. Altering both the
specificity of PPT cleavage and the extent of cleavage would
affect the generation of a proper PPT primer and, by extension,
the amount of linear viral DNAwith ends that can be integrated
successfully. Thus, the observed effects on the titer represent the
sum of the effects of mutations on the specificity of PPT
cleavage and the rate/extent of PPT cleavage.
Combining RT mutations with PPT mutations affects the
specificity of RNase H cleavage
The ends of the linear viral DNA are determined by the
RNase H cleavages that remove the tRNA and PPT primers;
Fig. 3. Percentages of consensus 2-LTR circle junctions for the different
combinations of RT-PPT mutations. The sequences of the PPTs are shown in the
leftmost column. Mutations in the PPT are in bold-type face. The percentages of
consensus 2-LTR circle junctions are given in integration-competent (IN+) and
integration deficient (IN−) backgrounds. The IN− viruses carry the D116N
active site mutation in HIV-1 integrase. nd = not determined.
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information about the specificity of RNase H cleavage. The
ends of the linear DNA can be ligated to form 2-LTR circles
(Coffin et al., 1997; Li et al., 2001; Whitcomb et al., 1990).
We have used the sequence of the 2-LTR circle junction as a
surrogate for the ends of the linear viral DNA; however, in a
normal infection, the linear viral DNA has several possible
fates. The vast majority of the linear viral DNAs that have
consensus ends are integrated into the host genome and form
proviruses; a portion of the remaining unintegrated DNA is
converted into 1-LTR and 2-LTR circles. Because integration
greatly enriches for the linear viral DNAs with aberrant ends
(those linear DNAs that cannot integrate), it is simpler to
screen for aberrant circle junctions in an IN+ infection. If
integration is blocked, then the whole population of linearFig. 4. The percentages of different types of 2-LTR circle junctions generated by inf
competent (IN+) vector. The types of 2-LTR circle junctions are shown on the left
indicated at the top, the names of the PPT mutants used in combination with the muta
The numbers of 2-LTR circle junction sequences analyzed for the mutants are indicDNAs is available to form circles; consequently, a more
accurate measurement of the percentage of linear DNAs with
consensus ends is measured by monitoring the 2-LTR circle
junctions formed in an IN− background. Because we wanted
to accurately measure both the percentage of aberrant ends
and understand the exact nature of the aberrant RNase H
cleavages, we measured the percentage of consensus 2-LTR
circle junctions using an infection with an IN− vector, then
we measured the different types of errors made by each of the
mutants with an IN+ vector (Fig. 3). The percentage of
consensus circle junctions measured with an IN− vector did
not correlate with the titer, suggesting that the combination of
mutations might affect the rate/extent of PPT cleavage
(discussed below). When compared to wild-type IN− (0.95
consensus), the mutants with either the Y501A or the Q475A
mutant paired either with the T-2 or the T-5 mutations have
approximately 0.5 consensus circle junctions (P b 0.0001
mutants versus wt). However, the fraction of consensus circle
junctions dropped to 0.24 for the Q475A + T-2-5 triple mutant
and to 0.16 for the Y501A + T-2-5 triple mutant [P b 0.0001
either (triple) mutant vs. wt; P b 0.0001 Q475A + T-2-5 vs.
Q475A + T-2 or Q475A + T-5 P b 0.0001 Y501A + T-2-5 vs.
Y501A + T-2]. This effect is particularly obvious for the
Y501A + T-2 mutant; however, a similar effect is seen (to a
lesser extent) with the Q475A +T-2mutant and the Y501A+ T-5
mutant. One explanation of the low titers seen with these
complex mutants is that RNase H cleaves the PPT inefficiently
and the relatively small amount of PPT primer means that only a
small amount of full-length linear viral DNA is synthesized
(discussed below).
We also determined the sequences of the circle junctions
obtained from an infection with IN+ vectors (Fig. 4). As
expected, the fraction of consensus circle junctions droppedecting cells with different combinations of RT-PPT mutations in an integration-
most column. The presence of wild-type or mutant (Y501A or Q475A) RT is
tions in RT are given. The percentages of each type of circle junction are shown.
ated below the name of the PPT. nd = not determined.
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reduction reflects the successful integration of consensus (and
some near-consensus) linear DNAs. T2–5 appears to be the
exception to this rule. The fraction of consensus sequences is, if
anything, lower with the IN− vector (0.06 vs. 0.03). However,
some non-consensus linear DNAs can be integrated. In
particular, linear DNAs whose sequences differ from consensus
by only a single (extra) nucleotide can also be used as substrates
for integration in infected cells. This is relevant because the
mutations in the PPT (alone) give rise to one-nucleotide
insertions; the effect is particularly important for T-5 and T-2-5
(see Fig. 5). This affects, in the opposite way, the proportion of
both consensus and non-consensus 2-LTR junctions. In
addition, integration events that derive from the linear viral
DNAs that have the extra nucleotide contribute to the overall
titer (Julias et al., 2004).
The Q475A + T-2, the Y501A + T-5 and the Y501A + T-2-5
mutants all showed an increase in the number of PPT + flanking
sequence insertions at the 2-LTR circle junction (P b 0.05).
However, the addition of the RNase H mutations to the PPT
mutations did not cause a significant increase in the number of
simple PPT insertions. This suggests that three of the complex
mutations (RT + PPT) are deficient in their ability to generate
and/or remove the normal PPT primer, implying that these
mutants had some problems with cleavage specificity as well as
with cleavage efficiency. However, the complex mutant
Q475 + T-5 showed only a modest increase in the insertion of
a PPT + flanking sequence at the 2-LTR junction, which is not
statistically significant.
One reason to pair the T-2, T-5 and T-2-5 mutations with the
Q475A and Y501A mutations is that the T-2, T-5 and T-2-5 each
cause, by themselves, a substantial increase in a particular type
of RNase H cleavage error, the one-nucleotide insertion (Fig. 5).
This insertion could be caused because RNase H miscleaves the
PPT initially; alternatively, RNase H (miscleavage) can cause a
one-nucleotide insertion if RNase H fails to remove the entire
PPT after the PPT is used as the plus-strand primer. In either
case, the one-nucleotide insertion results from an alteration in
the specificity of RNase H cleavage rather than simply from anFig. 5. Frequency of 1-nucleotide and 2-nucleotide insertions at the 2-LTR
circle junction for the RT-PPT mutants. The PPT mutations are listed in the
leftmost column, the RT mutations are listed in the columns on the right.
Below each RT are the proportions of 1-nucleotide and 2-nucleotide insertions.
nd = not determined.overall loss of cleavage specificity. We wanted to know how the
addition of the RT mutations, either Y501A or Q475A, would
affect the specificity of cleavage, in particular, whether the
presence of these RT mutations would alter the number of one-
nucleotide insertions caused by the T-2, T-5 and T-2-5
mutations. In every case, the addition of either the Q475A or
the Y501A reduced the percentage of one-nucleotide insertions
seen at the circle junction. For example, in the case of the T-5
mutation, which, when present by itself, causes almost half the
circle junctions (0.48) to contain a one-nucleotide insertion, the
addition of either the Q475A or the Y501A mutation
significantly reduced the number of one-nucleotide insertions
(0.06 and 0.12 respectively, P b 0.001 either mutant RT vs. wt
RT). In the case of the T-2 mutation, the percentage of one-
nucleotide insertions is lower (0.15) and the reduction seen with
the Q475A + T-2 mutant (to 0.04) is not statistically significant.
The fraction of one-nucleotide insertions seen for T-2-5 alone
(0.49) was reduced significantly by the addition of either the
Q475A or the Y501A mutation (0.23 and 0.29 respectively,
P b 0.01). This reduction in one base insertions is statistically
significant for both the Q475A + T-2-5 and the Y501 + T-2-5
mutants; however, the relatively large number of one-nucleotide
insertions seen with the RT + PPT complex mutants is also
significantly higher than the number of one-nucleotide inser-
tions seen with the wild-type virus (0.04, wt vs. Q475A + T-2-5
P b 0.0003, wt vs. Y501A + T-2-5 P b 0.0001). These results
suggest that the mutations in the protein (Q475A and Y501A)
not only reduce the specificity of the cleavage of the normal
PPT, but also alter the cleavage pattern of mutant PPTs that the
wild-type RT frequently miscleaves by one nucleotide. These
data reinforce the idea that the addition of the RNase H
mutations reduces the (altered) specificity of cleavage caused by
the mutations within the PPT.
Combining RT mutations with PPT mutations affects the rate of
PPT cleavage
Although the mutations affected the specificity of PPT
cleavage, this effect did not fully explain the effects of the
mutations on the titer, and we also measured the rate and extent
of DNA synthesis. The amounts of viral DNAs specific for the
initiation of DNA synthesis (RU5), for minus-strand DNA
transfer (U3) and for plus-strand DNA transfer were measured
using real-time PCR at 2 h, 4 h, 6 h and 24 h after infecting cells
with virus (Fig. 6). If the mutations affect the rate at which the
PPT primer is generated and used by RT, the amounts plus-
strand DNA transfer products would decrease relative to the
amounts of RU5 or U3 viral DNA, particularly at early times
after infection. Cells were infected with viruses containing WT
RT, WT RT combined with the T-2-5 PPT mutation, Q475A
mutation combined with the WT PPT, the T-2 mutation, the T-5
mutation, or the T-2-5 double-mutation in the PPT. To ensure
that the DNA used in the transfection process did not
significantly contribute to the amounts of DNA products
detected in infected cells, virions that contained the D110E
mutation in the polymerase active site of RT were prepared and
used as a control. Virions containing this defective RT are not
Fig. 6. Levels of viral DNA synthesis intermediates at various time points after infection. Minus-strand DNA synthesis was monitored by measuring the amount of
RU5; minus-strand transfer was monitored by measuring the amount of U3; (+) strand DNA transfer was monitored using PCR primers that span the primer binding
site (pbs). The viral DNA copy numbers are shown on the y axis, and the time points when DNAwas harvested are shown on the x axis. (A) Viral DNA synthesis for
mutant viruses containing the Q475A mutation in RT. (B) Viral DNA synthesis for mutant viruses containing the Y501A mutation in RT.
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measured in these samples resulted from plasmid carryover
from the transfection process used to generate the virus stocks.
The viral DNA copy numbers from the D110E control viruses
were dramatically lower (by more than 1000-fold) than the viral
DNA copy numbers in the experimental samples (data not
shown). We wanted to determine if the RNase H primer grip
mutant Q475A affects the rate of generation of the PPT primer
when combined with the PPT mutations T-2, T-5 and T-2-5 (Fig.
6A). The amounts of the RU5 viral DNA products produced 2 h,
4 h and 6 h after infection were reduced no more than 10-fold
relative to WT for all of the combinations containing Q475A
with the wild-type and mutant PPTs, or WT RT combined with
the wild-type PPT or the T-2-5 mutations. In all of these
samples, the relative amounts of U3 were similar to the amounts
of RU5 at each of the different time points, indicating that none
of the mutations substantially impaired minus-strand DNA
transfer. The amount of viral DNA specific for plus-strand DNA
transfer was reduced, and its rate of accumulation was delayed
slightly when WT RTwas paired with the T-2-5 PPT. When theQ475Amutation was paired with the normal PPT, the amount of
reverse transcription products specific for plus-strand DNA
transfer was lower than wild-type at 2 h, 4 h and 6 h after
infection. However, at the 24 h time point, the amount of plus-
strand DNA transfer was similar for wild-type and Q475A. This
indicated that the Q475A mutation delayed the generation of the
PPT primer, plus-strand initiation and/or plus-strand DNA
transfer. When combined with the PPT mutations, the Q475A
mutation in RT markedly delayed the accumulation of plus-
strand DNA.
We also wanted to determine if the Y501A mutation affected
the accumulation of viral DNA products specific for plus-strand
DNA transfer (Fig. 6B). The amount of DNA products specific
for RU5 were within 10-fold of the wild-type control with the T-
2-5 mutant, and for the Y501A mutant and for Y501Awith T-5,
and T-2-5. The amount of RU5 DNA measured for the Y501A
combined with the T-2 mutation was about 100-fold lower than
for WTat the earliest time point (2 h); however, the level of RU5
was similar at 24 h. The rate of accumulation of U3 DNA was
similar to the amount of RU5 for all of the mutants that carried
384 M.J. McWilliams et al. / Virology 348 (2006) 378–388Y501A. The generation and utilization of the PPT primer, as
measured by plus-strand DNA transfer, were modestly delayed
when the T-2-5 mutation was paired with WT RT; however, the
Y501A mutation dramatically delayed plus-strand DNA
transfer when combined with either the normal PPT or the T-2
mutation. The T-2-5 mutation in the PPT appeared to enhance
the rate of plus-strand priming by the Y501A RT mutant; Y501
showed faster priming with T-2-5 than with a wild-type PPT or
with either the T-2 or the T-5 mutations. In particular, the
combination of the Y501A mutation and the T-2 mutation
reduced the amount of plus-strand DNA dramatically, even at
the 24 h time point (Fig. 6B). These effects of the complex
mutations on the rate of plus-strand DNA transfer, when taken
together with the more modest affects on the specificity of PPT
cleavage, can explain the viral titer.
Discussion
The specificity of the RNase H cleavages that generate and
remove the PPT primer is remarkable when one considers that
the enzyme makes only one base-specific contact with its
nucleic acid substrate and that, outside the PPT, RNase H
cleavage appears to be relatively nonspecific. The specificity
with which RNase H cleaves the PPT depends on the
interactions of the nucleic acid and the enzyme; more
specifically, it depends on the structure of the nucleic acid
when it is in a complex with RT. This structure can be affected
(and the specificity of the PPT cleavage altered and/or the
generation of the PPT decreased) by making mutations in either
the nucleic acid or the protein (Coffin et al., 1997; Dash et al.,
2004; Julias et al., 2002, 2004; McWilliams et al., 2003; Powell
and Levin, 1996; Pullen et al., 1993; Rausch et al., 2002; Smith
et al., 1999; Snyder and Roth, 2000). There are critical contacts
between the protein and the nucleic acid involving the amino
acids Y501 and Q475. When RT is aligned to cleave the PPT/
U3 junction, the corresponding contact points for these amino
acids are at G2 and G5 in the PPT. The importance of these
contacts is illustrated by the observation that mutations in either
the amino acids involved in these contacts (Q475A and Y501A)
or mutations that convert G2 and G5 to Ts (T-2 and T-5) affect
the titer of the virus and the ability of the RNase H of RT to
appropriately cleave the PPT. One simple model to explain
these data would suggest that the contacts between G2 and
Y501 and between G5 and Q475 are critical. In a model of this
type, a double mutant in which both sides of an RT/PPT contact,
for example, G2 and Y501 (or G5 and Q475) are mutated,
would not be significantly more impaired than mutants in which
either G2 or Y501 was mutated. In contrast, the model predicts
combining mutations at Y501 and G5 (or Q475 and G2) would
have a much more profound effect. Alternatively, if the
mutations in the protein (or in the PPT) have significant effects
on the structure of the complex that go beyond the loss of a
simple contact, then the effects of combining the mutations are
less clearly predictable. There are reasons to anticipate the more
complex result. The effects of the corresponding RT and PPT
mutations do not exactly match (the effects of T-2 differ from
the effects of Y501A, and the effects of T-5 differ from theeffects of Q475A). One possible explanation could be that the
additional contacts between Q475 and Y501 and the nucleic
acid are important in the interactions between RT and the PPT.
However, we showed that mutating the other contact points in
the PPT do not profoundly affect either the titer of the virus or
the specificity of RNase H cleavage (McWilliams et al., 2003).
In addition, one would expect mutations that interrupt the run of
purines in the PPT (like T-2, T-5 and T-2-5) would affect the
structure of the nucleic acid both in solution and in a complex
with RT, which could affect the efficiency of cleavage, the
specificity of cleavage or both.
In terms of the effect on the titer, pairing the T-2 with Y501
had the greatest effect. The Y501A + T-2-5 mutant actually had
a higher titer than Y501A + T-2. Moreover, the titer of all the
complex mutants that involve T-5 and T-2-5 was fairly similar.
The effects of combining the mutants on the titer cannot be
explained solely by an effect on cleavage specificity. The 2-LTR
circle junctions, done in the absence of a functional integrase,
showed that the mutants combining either Y501A or Q475A
with T-2-5 produced fewer consensus circle junctions than did
the mutants in which T-2 or T-5 were combined with Q475A or
Y501A. Analysis of the rate and extent of minus-strand and
plus-strand viral DNA synthesis provides the explanation that,
although mutations in the PPT (alone) or in RT (alone) did not
have a profound effect on the rate or final amount of plus-strand
DNA synthesis, combining the PPT mutants and the RT mutants
did profoundly affect the synthesis of plus-strand DNA. This is
most easily explained as an affect on the rate (and extent) of
PPT cleavage. These data also help to explain the effects of the
double mutants on viral titer. The mutants that had the lowest
titers (for example, Q475A + T-2) cleaved the PPT with
moderate accuracy, but this cleavage was much slower than
normal. Although the synthesis of plus-strand DNA did catch
up to some extent at later time points, there was an effect on the
amount of plus-strand viral DNA, particularly in the case of the
Y501A + T-2 double mutant.
Given the profound delay in the synthesis of plus-strand
DNA, it is somewhat surprising that the titers of the double (and
triple) mutants are not lower than they are. By the 24 h time
points, the amount of plus-strand viral DNA recovered to a
greater or lesser extent depending on the mutant. This shows
that the reverse transcription complex is relatively stable and
that a substantial delay in the process is tolerated reasonably
well. This agrees with data showing that, if viral DNA
synthesis was not completed because the host cell is serum-
starved, the viral DNA intermediates are stable and viral
DNA synthesis could be efficiently completed when serum
was added back to the starved cells (Fritsh and Temin, 1977;
Varmus et al., 1977).
Taken together, our data argue that the interactions between
RT and the PPT are complex and multifaceted and that the
mutations in the PPTand/or the RTaffect the overall structure of
the complex (and RNase H cleavage), thus affecting both the
rate and specificity of PPT cleavage in ways that cannot be
explained simply by a small number of critical contacts between
the protein and the PPT. This conclusion is supported by the
data that show that, when the mutations in the PPT that cause
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paired with Y501A or Q475A, there is a reduction in the
number of 2-LTR circle junctions that have a single nucleotide
insertion. This means that the addition of the mutations in the
protein to the mutation(s) in the PPT causes an additional loss of
specificity, not only in terms of the ability of the RNase H to
make the exactly correct cleavage, but also in terms of RNase H
making a specific, if incorrect, cleavage. Moreover, the addition
of either the Q475A mutation or the Y501A mutation had a
profound affect on the ability of T-5 mutation in the PPT to
cause the specific one-nucleotide insertion error, reinforcing the
idea that the mutations have effects that go well beyond simply
disrupting the contacts between G2 and Y501 and between G5
and Q475. Combining mutations in RNase H and the PPT
appeared to have a greater effect on the initiation of plus-strand
DNA synthesis than on the specificity of cleavage. This
translated into an effect on the ability of the mutant viruses to
complete viral DNA synthesis at the 24 h time point and, in turn,
into an effect on viral titer.
This idea is supported by the fact that combining either the
Q475A or the Y501A mutations with the double PPT mutant, T-
2-5, had either a similar, or a smaller, effect on the titer of the
mutant viruses than did combining the Q475Awith either the T-
2 or the T-5 mutant, or Y501Awith T-5. This result was initially
somewhat surprising both because the T-2-5 double mutant by
itself had a more profound effect on the titer and the circle
junctions than did either the T-2 or -T-5 single mutations (by
themselves) and because, in the absence of integration, the
Q475A + T-2-5 and the Y501A + T-2-5 mutants gave rise to the
smallest numbers of consensus circle junctions. One factor that
contributed to the higher than expected titer of these complex
mutants is that the mutants generate a significant number of
linear DNAs that have one-nucleotide insertions; these slightly
aberrant linear DNAs can be successfully integrated (Julias et
al., 2004). However, even when this is taken into account, the
titer of the Y501A + T-2-5 and Q475A + T-2-5 mutants is
somewhat higher than would be expected.
In the context of wild-type RT, the double mutation (T-2-5)
has a more profound effect on the overall structure (and
cleavage) of the PPT than do either the T-2 or the T-5 single
mutations. Thus, the T-2-5 mutation is more deleterious when
the mutant PPTs are cleaved by the RNase H of wild-type RT,
but the T-2-5 mutation is somehow beneficial when the PPTs are
cleaved either by the Q475A or by the Y501A mutants. One
possible explanation is that the mutant PPTs appear to be
cleaved relatively slowly by all the RNases H (both wild-type
RT and the mutants). Although the double (T-2-5) mutations in
the PPT may reduce the specificity of cleavage, this double
mutation may disrupt the specialized structure conferred on the
PPT by the run of purines in the G-tract. This greater alteration
in the structure of the PPT could help the mutant RTs overcome
a severe problem in the rate of PPT cleavage. In this way, the
presence of two mutations in the G-tract could help an RNase H
with a mutation in an important contact (either Q475 or Y501)
cleave more rapidly even if there is a loss in the specificity of the
cleavage, an idea that is supported by the experiments that
measured the rates of plus-strand initiation. Viewed in this light,it appears to be more important, in terms of viral titer, for the
RNase H to cleave the PPT more rapidly and less specifically
than for the RNase H to retain greater specificity if the overall
rate of cleavage is low.
Materials and methods
Construction of the HIV-1 mutants
The one-round HIV-1 based viral vector pNLNgoMIVR-E-.
HSA has been described (Julias et al., 2001). Briefly, the vector
contains frameshift mutations that inactivate env and expresses
the murine cell surface marker CD24 from the nef reading
frame. Mutations in the PPT of the HIV-1 based vector
pNLNgoMIVR-E-.HAS were generated using a BspMI-cassette
strategy as previously described (McWilliams et al., 2003). The
mutations Q475A and Y501A in the RNase H primer grip of RT
were previously described (Julias et al., 2002). The vector-
encoding plasmids were analyzed by restriction endonuclease
digestion and DNA sequencing to confirm that only the desired
mutations were present in the vectors. Vectors containing the
D116N mutation in the integrase coding region were generated
by site-directed mutagenesis using the Quick-change kit
(Stratagene). Briefly, DNA oligonucleotides (Biosource Inter-
national) containing the necessary mutations were synthesized
and used in the site-directed mutagenesis protocol. The
mutagenesis substrate was pKS containing the Asp718 to
SalI fragment of pNLNgoMIVR-E-.HSA. The resulting
plasmid was analyzed by restriction endonuclease digestion,
and DNA sequence analysis was used to confirm that only
the desired mutation in IN was present; this plasmid is
called pKSINTD116N. The Asp718 to SalI fragment from
pKSINTD116N was cloned into pNLNgoMIVR-E-.HSA
vectors containing the desired PPT mutations, using Asp718
and SalI (these sites are each present once in the plasmid that
encodes the vector). The resulting plasmids were analyzed by
restriction endonuclease digestion and DNA sequence anal-
ysis. An NgoMIV restriction site is present near the 3′ end of
the RT coding region of the single-cycle vectors derived from
pNLNgoMIVR-E.HSA; another NgoMIV site is present 3′ of
the downstream LTR. The NgoMIV fragment of the plasmid
containing the desired mutant PPTs in the context of wild-
type or mutant HIV-1 integrase (D116N) was ligated into the
HIV-1 vector-encoding plasmid containing the Y501A or the
Q475A mutation in RT. The vectors containing mutations in
the PPT were previously described in both IN+ and IN−
backgrounds. The NgoMIV restriction sites were used to
combine the PPT (or PPT plus IN) mutations with the
mutations in RT.
Cells
The human embryonal kidney cell line 293 was obtained
from the American Type Culture Collection (ATCC). The
human osteosarcoma cell line HOS was obtained from Dr.
Richard Schwartz (Michigan State University; Lansing, MI).
293 and HOS cells were maintained in Dulbecco's modified
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bovine serum, 5% newborn calf serum and penicillin (50
units/ml) plus streptomycin (50 μg/ml) (Quality Biological).
Transfection, infection and phenotyping protocol
293 cells were transfected with 3 μg of pNLNgoMIVR-E-.
HSA and 1.0 μg of pHCMV-g (obtained from Dr. Jane Burns,
UCSD) using the calcium phosphate method. pHCMV-g
expresses the VSV-glycoprotein and can be used to generate
high-titer viral stocks (Bartz and Vodicka, 1997; Yee et al.,
1994). 293 cells were plated in 100-mm diameter dishes at a
density of 1.0 × 106 cells per plate on the day prior to
transfection. At this plating density, the cells were approxi-
mately 25% confluent on the day of transfection. The precipitate
was added to the 293 cells dropwise. Fresh medium was added
16 h after transfection. The 48-h supernatants were harvested,
clarified by low-speed centrifugation, and an aliquot was used
to infect HOS cells. The amount of p24 in the supernatant was
determined using the Coulter HIV-1 p24 antigen assay (Beck-
man Coulter); the p24 concentration was used to control for the
amount of virus in the samples. HOS cells were plated in 60-
mm diameter dishes at a density of 1.5 × 105 cells per plate on
the day prior to infection. The virus was allowed to absorb to the
cells for 4 h, then fresh medium was added. Forty-eight hours
after infection, the cells were harvested from the plate by
treatment with 1.0 ml of versene (Invitrogen), an additional 3 ml
of PBS was added, and then the cells were collected by
centrifugation, washed and resuspended in 200 μl PBS. The
cells were labeled with phycoerythrin-conjugated rat anti-
mouse CD24 monoclonal antibody (Pharmingen) using stan-
dard procedures, fixed with paraformaldehyde and subjected to
florescence-activated cell sorting to determine viral titer.
Transfections, infections and nucleic acid extraction for 2-LTR
circle junction analysis
293 cells were transfected with 5 μg of plasmid DNA
encoding the pNLNgoMIVR-E-.HSA vector and 3 μg of
pHCMV-g using the calcium phosphate method. The medium
on the cells was changed 16 h after infection. The 48
h supernatants were harvested and clarified by centrifugation,
and 4 ml of virus-containing supernatant was used to infect
HOS cells. The supernatants were left on the cells for 4 h, then
fresh medium was added. The total DNAwas isolated from the
HOS cells approximately 24 h after infection using the viral
blood DNA kit (Qiagen).
PCR amplification, cloning and sequencing of 2-LTR circle
junctions
The 2-LTR circle junctions were amplified in 100 μl
reactions using an upstream PCR primer that anneals near the
RU5 junctions and a downstream primer that anneals in the U3
region of the LTR. The sequence of the upstream primer was 5′-
CGATGAATTCGCTAACTAGGGAACCCACTGCT-3′; the
sequence of the downstream primer was 5′-GC CATTCTA-GAGTTCTCTCCTTTATTGGCCTC-3′. Ten microliters of
DNA from cells infected with the PPT mutants and 0.25 μl
each of the forward and reverse primers (100 nM final
concentration) were used with 90 μl of Platinum PCR Supermix
(Invitrogen) in each PCR reaction. The expected product is
approximately 350 bp long and has EcoRI and XbaI cleavage
sites introduced by the primers. The PCR products were
digested with EcoRI and XbaI and cloned into SK (Stratagene).
The 2-LTR circle junction clones were analyzed using
restriction enzyme digestion and DNA sequence analysis.
Determination of consensus 2-LTR circle junctions in an
IN− background
Transfections, infections, DNA isolation, PCR amplification
and cloning of the 2-LTR circle junction product were done
identically for the IN− viruses (containing the D116N mutation)
as for the integration-competent viruses. Consensus 2-LTR
circle junctions contain an ScaI recognition sequence. The
percentage of consensus 2-LTR circle junctions was determined
by digesting DNA from individual clones with ScaI and
fractionating the digestion products by agarose gel electropho-
resis. The SK plasmid into which the PCR products were cloned
also contains an ScaI recognition sequence; plasmids containing
a consensus 2-LTR circle junction will produce 2 bands upon
ScaI digestion and agarose gel electrophoresis.
Quantitative PCR
293 cells were transfected with the 3 μg of HIV-based
vectors and 2 μg of pHCMV-g (expresses the VSV envelope
glycoprotein) using the calcium phosphate method. Forty-eight
hour supernatants (8 ml) were harvested, centrifuged at low
speed to remove cell debris, filtered through 45 μm syringe
filter (Millipore) and treated for 30 min with RNase-free DNase
I [final concentration 10 units/ml (Roche)] at room temperature.
Six milliliters of the DNase-I-treated supernatants was concen-
trated to 0.5 ml using 20 ml 300,000 MWCO concentrators
(Vivascience). DMEM supplemented with 10% fetal bovine
serum was added to the concentrated virus to increase the
volume to 4.1 ml per sample. 0.5 ml of each virus was then
added to the HOS cells for 2 h. HOS cells were washed with 4
ml PBS, and DNAwas isolated using the EZ-1 DNA tissue kit
(QIAGEN). The elution volume was 100 μl for each sample.
Real-time PCR reactions were performed using the 2×
Universal Taqman Master Mix (Applied Biosystems) in 50 μl
reaction volumes using previously described Taqman reagents
and conditions (Julias et al., 2001). Viral DNA copy numbers
were determined using the ABI 7700 (Applied Biosystems) and
normalized for the amount of p24 antigen in the supernatant.
Statistical methods
Data were analyzed by log linear categorical analysis,
contingency table analysis and related methods. I × J Circle
Junction by Mutant tables were decomposed through the use of
the likelihood ratio chi-square statistics into independent
387M.J. McWilliams et al. / Virology 348 (2006) 378–388partitions to show associations between circle junction and/or
mutant groupings and categories. Subsets of pertinent group-
ings were followed up with traditional 2 × 2 chi-square analyses
and Fisher's Exact tests.
Acknowledgments
The authors thank Refika Turnier, Elizabeth Shanklin-
Selby and Guity Mohammadi for help with FACS and the
SAIC-Frederick Laboratory of Molecular Technology, espe-
cially Claudia Stewart, for technical support. We also thank
Hilda Marusiodis for assistance in manuscript preparation
and Mike Abrams for critically reading the manuscript. This
publication has been funded in whole or in part with Federal
funds from the National Cancer Institute, National Institutes
of Health, under Contract No. NO1-CO-12400. The content
of this publication does not necessarily reflect the views or
policies of the Department of Health and Human Services
nor does mention of trade names, commercial products or
organizations imply endorsement by the U.S. Government.
This research was supported [in part] by the Intramural
Research Program of the NIH, National Cancer Institute,
Center for Cancer Research.
References
Bartz, S.R., Vodicka, M.A., 1997. Production of high-titer human immunode-
ficiency virus type 1 pseudotyped with vesicular stomatitis virus
glycoprotein. Methods 12, 337–342.
Coffin, J.M., Hughes, S.H., Varmus, H.E., 1997. Editors of Retroviruses. Cold
Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
Dash, C., Rausch, J.W., Le Grice, S.F., 2004. Using pyrrolo-deoxycytosine to
probe RNA/DNA hybrids containing the human immunodeficiency virus
type-1 3′ polypurine tract. Nucleic Acids Res. 32, 1539–1547.
Dudding, L.R., Mizrahi, V., 1993. Rapid kinetic analysis of a point mutant of
HIV-1 reverse transcriptase lacking ribonuclease H activity. Biochemistry
32, 6116–6120.
Dudding, L.R., Nkabinde, N.C., Mizrahi, V., 1991. Analysis of the RNA- and
DNA dependent DNA polymerase activities of point mutants of HIV-1
reverse transcriptase lacking ribonuclease H activity. Biochemistry 30,
10498–10506.
Fritsh, E.F., Temin, H.M., 1977. Inhibition of viral DNA synthesis in stationary
chicken embryo fibroblasts infected with avian retroviruses. J. Virol. 24,
46146–46149.
Furfine, E.S., Reardon, J.E., 1991. Human immunodeficiency virus reverse
transcriptase ribonuclease H: specificity of tRNA-lys-primer excision.
Biochemistry 30, 7041–7046.
Gao, H.-Q., Boyer, P.L., Arnold, E., Hughes, S.H., 1998. Effects of mutations in
the polymerase domain on the polymerase, RNase H and strand transfer
activities of human immunodeficiency virus type 1 reverse transcriptase. J.
Mol. Biol. 277, 559–572.
Guaitiao, J.P., Zuniga, R.A., Roth, M.J., Leon, O., 2004. Lysine directed cross-
linking of viral DNA–RNA:DNA hybrid substrate to the isolated RNase H
domain of HIV-1 reverse transcriptase. Biochemistry 10, 1302–1308.
Huang, H., Chopra, R., Verdine, G.L., Harrison, S.C., 1998. Structure of a
covalently trapped catalytic complex of HIV-1 reverse transcriptase:
implications for drug resistance. Science 282, 1669–1675.
Hughes, S.H., Arnold, E., Hostomsky, Z., 1998. RNase H of retroviral reverse
transcriptases. In: Crouch, R.J., Toulmé, J.J. (Eds.), Chapter in Ribonu-
cleases H. Les Editions INSERM, Paris.
Jacobo-Molina, A., Ding, J., Nanni, R.G., Clark Jr., A.D., Lu, X., Tantillo, C.,
Williams, R.L., Kamer, G., Ferris, A.L., Clark, P., Hizi, A., Hughes, S.H.,
Arnold, E., 1993. Crystal structure of human immunodeficiency virus type 1reverse transcriptase complexed with double-stranded DNA at 3.0Å
resolution shows bent DNA. Proc. Natl. Acad. Sci. U.S.A. 90, 6320–6324.
Julias, J.G., Ferris, A.L., Boyer, P.L., Hughes, S.H., 2001. Replication of
phenotypically mixed human immunodeficiency virus type 1 virions
containing catalytically active and catalytically inactive reverse transcrip-
tase. J. Virol. 75, 6537–6546.
Julias, J.G., McWilliams, M.J., Sarafianos, S.G., Arnold, E., Hughes, S.H.,
2002. Mutations in the RNase H domain of HIV-1 reverse transcriptase
affect the initiation of DNA synthesis and the specificity of RNase H
cleavage in vivo. Proc. Nat. Acad. Sci. U.S.A. 99, 9515–9520.
Julias, J.G., McWilliams, M.J., Sarafianos, S.G., Alvord, W.G., Arnold, E.,
Hughes, S.H., 2004. Effects of mutations in the G tract of the human
immunodeficiency virus type 1 polypurine tract on virus replication and
RNase H cleavage. J. Virol. 78, 13315–13324.
Kopka, M.L., Lavelle, L., Han, G.W., Ng, H.L., Dickerson, R.E., 2003. An
unusual sugar conformation in the structure of an RNA/DNA decamer of the
polypurine tract may affect recognition by RNase H. J. Mol. Biol. 334,
653–665.
Kulkosky, J., Katz, R.A., Skalka, A.M., 1990. Terminal nucleotides of the
preintegrative linear form of HIV-1 DNA deduced from the sequence of
circular DNA junctions. J. Acquired Immune Defic. Syndr. 3, 852–858.
Kvaratskhelia, M., Budihas, S.R., Le Grice, S.F., 2002. Pre-existing distortions
in nucleic acid structure aid polypurine tract selection by HIV-1 reverse
transcriptase. J. Biol. Chem. 277, 16689–16696.
Li, L., Olvera, J.M., Yoder, K.E., Mitchell, R.S., Butler, S.L., Lieber, M., Martin,
S.L., Bushman, F.D., 2001. Role of the non-homologous DNA end joining
pathway in the early steps of retroviral infection. EMBO J. 20, 3273–3281.
McWilliams, M.J., Julias, J.G., Sarafianos, S.G., Alvord, W.G., Arnold, E.,
Hughes, S.H., 2003. Mutations in the 5′ end of the human immunodefi-
ciency virus type 1 polypurine tract affect RNase H cleavage specificity and
virus titer. J. Virol. 77, 11150–11157.
Mizrahi, V., Usdin, M.T., Harington, A., Dudding, L.R., 1990. Site-directed
mutagenesis of the conserved Asp-443 and Asp-498 carboxy-terminal
residues of HIV-1 reverse transcriptase. Nucleic Acids Res. 18,
5359–5363.
Mizrahi, V., Brooksbanks, R.L., Nkabinde, N.C., 1994. Mutagenesis of the
conserved aspartic acid 443, glutamic acid 478, aspargine 494, and aspartic
acid 498 residues in the ribonuclease H domain of p66/p51 human
immunodeficiency virus type I reverse transcriptase. J. Biol. Chem. 269,
19245–19249.
Powell, M.D., Levin, J.G., 1996. Sequence and structural determinants required
for priming of plus-strand DNA synthesis by the human immunodeficiency
virus type 1 polypurine tract. J. Virol. 70, 5288–5296.
Pullen, K.A., Champoux, J.J., 1990. Plus-strand origin for human immunode-
ficiency virus type 1: implications for integration. J. Virol. 64, 6274–6277.
Pullen, K.A., Ishimoto, L.K., Champoux, J.J., 1992. Incomplete removal of the
RNA primer for minus-strand DNA synthesis by human immunodeficiency
virus type 1 reverse transcriptase. J. Virol. 66, 367–373.
Pullen, K.A., Rattray, A.J., Champoux, J.J., 1993. The sequence features
important for plus-strand priming by human immunodeficiency virus type 1
reverse transcriptase. J. Biol. Chem. 268, 6221–6227.
Rattray, A.J., Champoux, J.J., 1989. Plus-strand priming by Moloney murine
leukemia virus. The sequence features important for cleavage by RNase H. J.
Mol. Biol. 208, 445–456.
Rausch, J.W., Lener, D., Miller, J.T., Julias, J.G., Hughes, S.H., Le Grice, S.F.,
2002. Altering the RNase H primer grip of human immunodeficiency virus
reverse transcriptase modifies cleavage specificity. Biochemistry 41,
4856–4865.
Repaske, R., Hartley, J.W., Kavlick, M.F., O'Neill, R.R., Austin, J.B., 1989.
Inhibition of RNase H activity and viral replication by single mutations in
the 3′ region of Moloney murine leukemia virus reverse transcriptase. J.
Virol. 63, 1460–1464.
Sarafianos, S.G., Das, K., Tantillo, C., Clark Jr., A.D., Ding, J., Whitcomb, J.,
Gait, M., Boyer, P.L., Hughes, S.H., Arnold, E., 2001. Crystal structure of
HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA.
EMBO J. 20, 1449–1461.
Schatz, O., Cromme, F.V., Naas, T., Lindemann, D., Mous, J., Le Grice, S.F.J.,
1990. Inactivation of the RNase H domain of HIV-1 reverse transcriptase
388 M.J. McWilliams et al. / Virology 348 (2006) 378–388blocks viral infectivity. Gene Regulation and AIDS. Portfolio, Houston,
pp. 293–404.
Smith, J.S., Roth, M., 1992. Specificity of human immunodeficiency virus-1
reverse transcriptase-associated ribonuclease H in removal of the minus-
strand primer, tRNA(Lys3). J. Biol. Chem. 267, 15071–15079.
Smith, C.M., Smith, J.S., Roth, M.J., 1999. RNase H requirements for the
second strand transfer reaction of human immunodeficiency virus type 1
reverse transcription. J. Virol. 73, 6573–6581.
Snyder, C.S., Roth, M.J., 2000. Comparison of second-strand requirements
and RNase H cleavages catalyzed by human immunodeficiency virus
type 1 reverse transcriptase (RT) and E478Q RT. J. Virol. 74,
9668–9679.
Tisdale, M., Schultze, T., Larder, B.A., Moelling, K., 1991. Mutations within theRNase H domain of HIV-1 reverse transcriptase abolish viral infectivity. J.
Gen. Virol. 72, 59–66.
Varmus, H.E., Padgett, T., Heasley, S., Simon, G., Bishop, J.M., 1977. Cellular
functions are required for the synthesis and integration of avian sarcoma
virus-specific DNA. Cell 11, 307–319.
Whitcomb, J.M., Hughes, S.H., 1992. Retroviral reverse transcription and
integration: progress and problems. Annu. Rev. Cell Biol. 8, 275–306.
Whitcomb, J.M., Kumar, R., Hughes, S.H., 1990. Sequence of the circle
junction of human immunodeficiency virus type 1: implications for reverse
transcription and integration. J. Virol. 64, 4903–4906.
Yee, J.K., Friedmann, T., Burns, J.C., 1994. Generation of high-titer
pseudotyped retroviral vectors with very broad host range. Methods Cell
Biol. 43, 99–112.
